Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc (NYSE:KVUE), the company behind popular consumer products like Tylenol and Listerine. What Happened: Starboard Value is pushing for changes at Kenvue, which was spun off from Johnson & Johnson (NYSE:JNJ) last year and has a market value of over $40 billion, reported The Wall Street Journal, citing people familiar with the matter. Despite having some of the best consumer brands in the industry, Kenvue’s stock has underperformed its peers and the broader market since its debut over a year ago. The ex…
